Saladaga, Mechel C.
HRN: 28-63-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
AMPICILLIN 1GM (VIAL)
04/06/2026
04/12/2026
IVT
2GMS
Q6HRS
PROM X 7 HOURS
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: